%0 Journal Article
%T 非霍奇金淋巴瘤骨髓受累的诊断技术与预后评估
%A 克晓燕审校
%A 王晶
%A 高帆综述
%J 肿瘤防治研究
%D 2018
%R 10.3971/j.issn.1000-8578.2018.18.0061
%X 摘要 骨髓受累（bone marrow involvement, BMI）是非霍奇金淋巴瘤不良预后的标志，因其在评估预后和指导治疗中举足轻重的地位，而成为非霍奇金淋巴瘤（NHL）初诊时必备的评估内容。在其检出手段中，骨髓活检（bone marrow biopsy, BMB）具备基石的地位，但随着抽吸物的流式细胞学技术、细胞遗传学技术以及分子生物学技术等技术进步，其诊断意义也在提升，并展现出评估预后的价值。同时，PET-CT作为一种有效的检出方法，也逐渐成为研究热点。本文将综述这些检出方法，同时对BMI新近的预后研究进行回顾，以展望其研究前景
%K A Case Report and Literature Review
%K Mediastinal and Left Lung Malignancy Coupling with Suspicion for Esophagus Cancer: A Case Report
%K Clinical Features and Prognostic Factors of Primary Gastrointestinal Non-Hodgkin's Lymphoma
%K Successful Salvage Therapy with ABVD on Refractory Diffuse Large B-cell Lymphoma: A Case Report
%K Current Research Status of NF-kappa B Related Molecular Pathway in Diffuse Large B Cell Lymphoma
%K Expression of Toll-like Receptor 4 in Lymphoma Cell Lines and Its Effect on Cells Proliferation and Drug Resistance
%K Clinical Characteristics and Prognosis of 123 Patients with Diffuse Large B-cell Lymphoma of Waldeyer’s Ring
%K Differences of Clinical Features and Short-term Efficacy Between Diffuse Large B-cell Lymphomas of HIV-infected and Non-HIV-infected Patients
%U http://www.zlfzyj.com/CN/abstract/abstract9217.shtml